KWAG
ANIP icon

Kiely Wealth Advisory Group’s ANI Pharmaceuticals ANIP Stock Holding History

Kiely Wealth Advisory Group’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$60 Hold
1
– – ﹤0.01% 312
2024
Q3 		$62 Hold
1
– – ﹤0.01% 313
2024
Q2 		$56 Hold
1
– – ﹤0.01% 301
2024
Q1 		$66 Hold
1
– – ﹤0.01% 282
2023
Q4 		$55 Buy
+1
New +$55 ﹤0.01% 266

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Kiely Wealth Advisory Group's ANIP Position: Q4 2024 in Review

Kiely Wealth Advisory Group held its ANI Pharmaceuticals (ANIP) position steady in Q4 2024 at 1 share worth $60. The position accounts for ﹤0.01% of the portfolio, ranked #312.

Kiely Wealth Advisory Group first reported a position in ANIP in Q4 2023 and has held it in 5 quarters since. The position peaked at $66 in Q1 2024. 205 funds tracked by Wall St. Rank hold ANIP as of Q4 2024.

  • Kiely Wealth Advisory Group held 1 share of ANI Pharmaceuticals worth $60 as of Q4 2024.
  • Kiely Wealth Advisory Group left its ANI Pharmaceuticals share count unchanged in Q4 2024.
  • ANI Pharmaceuticals made up ﹤0.01% of Kiely Wealth Advisory Group's portfolio in Q4 2024, its #312 holding.
  • Kiely Wealth Advisory Group first reported a position in ANI Pharmaceuticals in Q4 2023 and has held it in 5 quarters since.
  • Kiely Wealth Advisory Group's ANI Pharmaceuticals position peaked at $66 in Q1 2024.
  • 205 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2024.

Based on Kiely Wealth Advisory Group's 13F filing for Q4 2024, filed 12 Feb 2025.